Korea United Pharm Inc. (033270.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 311.49B |
| Enterprise Value | 285.22B |
| P/E Ratio | 6.73 |
| PEG Ratio | 0.14 |
| Price/Sales Ratio | 0.88 |
| Price/Book Ratio | 0.61 |
| Enterprise/Revenue | 0.78 |
| Enterprise/EBITDA | 4.15 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.14 |
| Operating Margin | 0.16 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 288.76B |
| Revenue/Share | 18,303.92 |
| Gross Profit | 175.41B |
| EBITDA | 60.47B |
| Net Income | 38.31B |
| Diluted EPS | 2,614.37 |
Balance Sheet
| Total Cash | 171.65B |
| Total Cash/Share | 10,788.23 |
| Total Debt | 13.32B |
| Total Debt/Equity | 0.03 |
| Current Ratio | 3.36 |
| Book Value Per Share | 28,895.42 |
Price History
| 52-Week Change | -18.86 |
| 52-Week High | 22,450 |
| 52-Week Low | 16,460 |
| Moving Average 50 Days | 18,545.6 |
| Moving Average 200 Days | 19,290.2 |
Statistics
| Average Volume | 31,766 |
| Shares Outstanding | 14.44M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 610 |
| Trailing Annual Dividend Yield | 3.44 |
| Payout Ratio | 0.17 |
| Last Split Factor | 51:50 |
| Last Split Date | January 20, 2014 |
AD
